A prospective, randomized, open-label, phase III clinical trial of NovoTTF-100A versus best standard of care chemotherapy in patients with recurrent glioblastoma Meeting Abstract
| Authors: | Stupp, R.; Kanner, A.; Engelhard, H.; Heidecke, V.; Taillibert, S.; Lieberman, F. S.; V. Dbalý, V.; Kirson, E. D.; Palti, Y.; Gutin, P. H. |
| Abstract Title: | A prospective, randomized, open-label, phase III clinical trial of NovoTTF-100A versus best standard of care chemotherapy in patients with recurrent glioblastoma |
| Meeting Title: | 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 28 |
| Issue: | 18 Suppl. |
| Meeting Dates: | 2010 Jun 4-8 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2010-06-20 |
| Start Page: | 950s |
| Language: | English |
| ACCESSION: | WOS:000208880800019 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2010.28.18_suppl.lba2007 |
| Notes: | Meeting Abstract: LBA2007 -- Source: Wos |
